Time course and predictors of neurological deterioration after intracerebral hemorrhage

Stroke

Volumn 46, Issue 3, 2015, Pages 647-652

  Lord, Aaron S ^a   Gilmore, Emily ^b   Choi, H Alex ^c   Mayer, Stephan A ^d   Hanley, D F ^e   Butcher, K ^e   Davis, S ^e   Gregson, B ^e   Lees, K R ^e   Lyden, P ^e   Mayer, S ^e   Muir, K ^e   Steiner, T ^e  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e NONE

Author keywords

Cerebral hemorrhage; Glasgow Coma Scale; Neurological disorders

Indexed keywords

TROPONIN;

ACUTE NEUROLOGICAL DETERIORATION; ADULT; AGE; AGED; ARTICLE; BRAIN EDEMA; BRAIN HEMATOMA; BRAIN HEMORRHAGE; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DELAYED NEUROLOGICAL DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FEVER; GLASGOW COMA SCALE; HUMAN; HYPERACUTE NEUROLOGICAL DETERIORATION; INFECTION; INJURY SEVERITY; INTERVENTRICULAR HEMORRHAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NEUROIMAGING; NEUROLOGICAL COMPLICATION; NEUROLOGICAL DETERIORATION; PRIORITY JOURNAL; PROGNOSIS; RANKIN SCALE; RETROSPECTIVE STUDY; SUBACUTE NEUROLOGICAL DETERIORATION; CEREBRAL HEMORRHAGE; COMPLICATION; CONTROL GROUP; HEMATOMA; MULTIVARIATE ANALYSIS; NEUROLOGIC DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; CEREBRAL HEMORRHAGE; CONTROL GROUPS; FEMALE; GLASGOW COMA SCALE; HEMATOMA; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NERVOUS SYSTEM DISEASES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84929292051     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007704     Document Type: Article

References (9)

1. Sakamoto Y, Koga M, Yamagami H, Okuda S, Okada Y, Kimura K, et al; SAMURAI Study Investigators. Systolic blood pressure after intravenous antihypertensive treatment and clinical outcomes in hyperacute intracerebral hemorrhage: the stroke acute management with urgent riskfactor assessment and improvement-intracerebral hemorrhage study. Stroke. 2013;44:1846-1851. doi: 10.1161/STROKEAHA.113.001212.
2. Leira R, Dávalos A, Silva Y, Gil-Peralta A, Tejada J, Garcia M, et al; Stroke Project, Cerebrovascular Diseases Group of the Spanish Neurological Society. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology. 2004;63:461-467.
3. Mayer SA, Sacco RL, Shi T, Mohr JP. Neurologic deterioration in noncomatose patients with supratentorial intracerebral hemorrhage. Neurology. 1994;44:1379-1384.
4. Flemming KD, Wijdicks EF, St Louis EK, Li H. Predicting deterioration in patients with lobar haemorrhages. J Neurol Neurosurg Psychiatry. 1999;66:600-605.
5. Rodriguez-Luna D, Piñeiro S, Rubiera M, Ribo M, Coscojuela P, Pagola J, et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol. 2013;20:1277-1283. doi: 10.1111/ene.12180.
6. Sorimachi T, Osada T, Baba T, Inoue G, Atsumi H, Ishizaka H, et al. The striate artery, hematoma, and spot sign on coronal images of computed tomography angiography in putaminal intracerebral hemorrhage. Stroke. 2013;44:1830-1832. doi: 10.1161/STROKEAHA.113.001498.
7. Britton M, Rödén A. Progression of stroke after arrival at hospital. Stroke. 1985;16:629-632.
8. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al; FAST Trial Investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358:2127-2137. doi: 10.1056/NEJMoa0707534.
9. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2005;352:777-785. doi: 10.1056/NEJMoa042991.